[HTML][HTML] Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - Springer
Aims/hypothesis We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón… - Diabetologia, 2016 - search.proquest.com
Methods We conducted a prospective, randomised, open-label, blinded endpoint trial of
2,012 hypertensive patients without diabetes, 976 men and 1,036 women, 52.7±13.6 years …

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2015 - europepmc.org
Methods We conducted a prospective, randomised, open-label, blinded endpoint trial of
2,012 hypertensive patients without diabetes, 976 men and 1,036 women, 52.7±13.6 years …

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2015 - infona.pl
Aims/hypothesis We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - researchgate.net
New-onset diabetes was not a pre-specified endpoint in the published trial design [1].
However, the authors note that the MAPEC trial was designed to investigate, as major …

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.

RC Hermida, DE Ayala, A Mojón, JR Fernández - 2016 - cabidigitallibrary.org
Aims/hypothesis: We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

[PDF][PDF] Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - siditalia.it
Aims/hypothesis We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

[HTML][HTML] Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - Springer
Methods We conducted a prospective, randomised, open-label, blinded endpoint trial of
2,012 hypertensive patients without diabetes, 976 men and 1,036 women, 52.7±13.6 years …

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - 2016 - pubmed.ncbi.nlm.nih.gov
Aims/hypothesis We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

[引用][C] Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - infona.pl
Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type
2 diabetes: a randomised controlled trial × Close The Infona portal uses cookies, ie strings of …